Subrata K Pore

Pitt ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2019
Publications (10 Years): 3

Top Topics

Prostate Cancer

Radical Prostatectomy

Intellectual Disability

Top Venues

Molecular cancer therapeutics

Journal of cellular biochemistry

Institute of Advanced Study in Science and Technology

Indian Institute of Chemical Technology (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute of Advanced Study in Science and Technology Jul 1o 2019

India

Ramalingaswami Fellow :: Life Science Division

Education History

Indian Institute of Chemical Technology Aug 5o 2007 - Jan 31o 2014

India

PHD :: Biomaterials group

Publications

Krishna B Singh, Eun-Ryeong Hahm, Subrata K Pore, Shivendra V Singh
Leelamine Is a Novel Lipogenesis Inhibitor in Prostate Cancer Cells In Vitro and In Vivo. Molecular cancer therapeutics 18 (10) (2019)
Subrata K Pore, Anirban Ganguly, Samaresh Sau, Sudhakar Godeshala, Anantha K Kanugula, Ramesh Ummanni, Srigiridhar Kotamraju, Rajkumar Banerjee
N-end rule pathway inhibitor sensitizes cancer cells to antineoplastic agents by regulating XIAP and RAD21 protein expression. Journal of cellular biochemistry 121 (1) (2019)
Subrata K Pore, Eun-Ryeong Hahm, Su-Hyeong Kim, Krishna B Singh, Lea Nyiranshuti, Joseph D Latoche, Carolyn J Anderson, Juraj Adamik, Deborah L Galson, Kurt R Weiss, Rebecca J Watters, Boeun Lee, Prashant N Kumta, Shivendra V Singh
A Novel Sulforaphane-Regulated Gene Network in Suppression of Breast Cancer-Induced Osteolytic Bone Resorption. Molecular cancer therapeutics 19 (2) (2019)